| MDR | Multidrug-Resistant |
| AI | Artificial Intelligence |
| GLP-1 | Glucagon-Like Peptide-1 |
| PPIs | Protein–Protein Interactions |
| CADD | Computer-Aided Drug Design |
| SPSS | Solid-Phase Peptide Synthesis |
| TFA | Trifluoroacetic Acid |
| LPSS | Liquid-Phase Peptide Synthesis |
| CuAAC | Copper-catalyzed Azide–Alkyne Cycloaddition |
| SMAP | Staphylococcus Aureus Antimicrobial Peptide |
| HRMS | High-Resolution Mass Spectrometry |
| MAM | Multi-Attribute Monitoring |
| NMR | Nuclear Magnetic Resonance |
| CD | Circular Dichroism |
| AMP | Antimicrobial Peptide |
| ACP | Anticancer Peptide |
| PDCs | Peptide–Drug Conjugates |
| APCs | Antigen-Presenting Cells |
| DC | Dendritic Cell |
| CTL | Cytotoxic T Lymphocyte |
| GM-CSF | Granulocyte–Macrophage Colony-Stimulating Factor |
| AML | Acute Myeloid Leukemia |
| NSCLC | Non-Small Cell Lung Cancer |
| STING | Stimulator of Interferon Genes |
| CVDs | Cardiovascular Diseases |
| NP | Natriuretic Peptide |
| RAAS | Renin–Angiotensin–Aldosterone System |